Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans

Infection and Immunity

Volumn 65, Issue 9, 1997, Pages 3822-3827

  Zhang, Mason X ^a   Lupan, David M ^a   Kozel, Thomas R ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; EGTAZIC ACID; IMMUNOGLOBULIN G ANTIBODY; MANNAN;

ADULT; ARTICLE; CANDIDA ALBICANS; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SERUM; YEAST CELL;

EID: 0030931389     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.9.3822-3827.1997     Document Type: Article

References (22)

1. Fraker, P. J., and J. C. Speck, Jr. 1978. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:849-857.
2. Gelfand, J. A., D. L. Hurley, A. S. Fauci, and M. M. Frank. 1978. Role of complement in host defense against experimental disseminated candidiasis. J. Infect. Dis. 138:9-16.
3. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
4. Horstmann, R. D., H. J. Sievertsen, J. Knobloch, and V. A. Fischetti. 1988. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. USA 85:1657-1661.
5. Kanbe, T., M. A. Jutila, and J. E. Cutler. 1992. Evidence that Candida albicans binds via a unique adhesion system on phagocytic cells in the marginal zone of the mouse spleen. Infect. Immun. 60:1972-1978.
6. Kazatchkine, M. D., D. T. Fearon, and K. F. Austen. 1979. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between Band β1H for cell-bound C3b. J. Immunol. 122:75-81.
7. Kobayashi, H., N. Shibata, H. Mitobe, Y. Ohkubo, and S. Suzuki. 1989. Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis. Arch. Biochem. Biophys. 272:364-375.
8. Kocourek, J., and C. E. Ballou. 1969. Method for fingerprinting yeast cell wall mannans. J. Bacteriol. 100:1175-1181.
9. Kozel, T. R., R. R. Brown, and G. S. T. Pfrommer. 1987. Activation and binding of C3 by Candida albicans. Infect. Immun. 55:1890-1894.
10. Kozel, T. R., and G. S. T. Pfrommer. 1986. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect. Immun. 52:1-5.
11. Kozel, T. R., L. C. Weinhold, and D. M. Lupan. 1996. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect. Immun. 64:3360-3368.
12. Lehmann, P. F., and E. Reiss. 1980. Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients. Mycopathologia 70:89-93.
13. Lyon, F. L., R. F. Hector, and J. E. Domer. 1986. Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component. J. Med. Vet. Mycol. 24:359-367.
14. Morelli, R., and L. T. Rosenberg. 1971. Role of complement during experimental Candida infection in mice. Infect. Immun. 3:521-523.
15. Nelson, R. D., N. Shibata, R. P. Podzorski, and M. J. Herron. 1991. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin. Microbiol. Rev. 4:1-19.
16. Peat, S., W. J. Whelan, and T. E. Edwards. 1961. Polysaccharides of baker's yeast. IV. Mannan. J. Chem. Soc. 1:29-34.
17. Pfrommer, G. S. T., S. M. Dickens, M. A. Wilson, B. J. Young, and T. R. Kozel. 1993. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule. Infect. Immun. 61:4360-4366.
18. Schenkein, H. A., and S. Ruddy. 1981. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway. J. Immunol. 126:11-15.
19. Tack, B. F., J. Janatova, M. L. Thomas, R. A. Harrison, and C. H. Hammer. 1981. The third, fourth, and fifth components of human complement: isolation and biochemical properties. Methods Enzymol. 80:64-101.
20. Tsang, V. C. W., and P. P. Wilkins. 1991. Optimum dissociating condition for immunoaffinity and preferential isolation of antibodies with high specific activity. J. Immunol. Methods 138:291-299.
21. Zhang, M. X., and T. R. Kozel. Unpublished data.
22. Zhang, M. X., D. M. Lupan, and T. R. Kozel. 1997. Effect of structural modification of the Candida albicans surface on activation of the classical and alternative complement pathways, abstr. F-108, p. 278. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.